Description

Drospifem 20 (Ethinylestradiol, Drospirenone) Coated Tablets 0.02 mg/3 mg. №28

Ingredients

Each coated tablet contains 0.02 mg of ethinylestradiol and 3 mg of drospirenone.

Dosage

The recommended dosage is one tablet daily for 28 days, starting on the first day of the menstrual cycle.

Indications

Drospifem 20 is indicated for the prevention of pregnancy. It is also used to treat symptoms of premenstrual dysphoric disorder (PMDD) and moderate acne in women who desire contraception.

Contraindications

Do not use Drospifem 20 if you are pregnant, have a history of blood clots, or have certain types of cancer. It is important to discuss your medical history with your healthcare provider before starting this medication.

Directions

Take one tablet daily at the same time each day with or without food. Follow the instructions provided in the package insert for optimal effectiveness.

Scientific Evidence

Studies have shown that the combination of ethinylestradiol and drospirenone in Drospifem 20 is highly effective in preventing pregnancy. Research has also demonstrated the efficacy of drospirenone in reducing symptoms of PMDD and acne.

Additional Information

It is important to note that Drospifem 20 does not protect against sexually transmitted infections (STIs). Contact your healthcare provider if you experience any severe side effects while taking this medication.

Pharmacological Effects: Drospifem 20 works by inhibiting ovulation, thickening cervical mucus, and altering the endometrium, preventing fertilization and implantation.

Clinical Trials: Clinical trials have shown Drospifem 20 to be as effective as other combined oral contraceptives in preventing pregnancy, with a similar side effect profile.